Financials
- Market Capitalization 1.73 B
- Employee 14 K
- Founded 2023
- CEO Paul R. N. Kirchgraber
- Website www.fortrea.com
- Headquarter North Carolina, United States
- FIGI BBG01GZF9VY6
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2094 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.68 USD | -1.48% | +1.85% | +19.74% | -7.58% | 1.78 B USD | ||
| 2104 | GHRS GH Research PLC - Ordinary Shares | 27.25 USD | -2.47% | -3.47% | -3.27% | +92.44% | 1.69 B USD | ||
| 2115 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 19.28 USD | -1.33% | -2.43% | +1.42% | +16.85% | 1.72 B USD | ||
| 2140 | FBRX Forte Biosciences, Inc. - Common Stock | 76.99 USD | 0.00% | +0.08% | +0.40% | +162.32% | 1.63 B USD |